SWHR attended MichBIO 2023 and gave the presentation “Addressing Disparities Through Patient, Provider, and Policymaker Collaborations: Women’s Health and Autoimmune Disease Case Study.”
Polycystic ovary syndrome, commonly referred to as PCOS, is an endocrine disorder that affects the balance of reproductive hormones and affects an estimated 5 million women in the United States.
To bring attention to these research and care gaps and help support individuals impacted by uterine health conditions, SWHR has added uterine health to the Women’s Health Equity Initiative campaign this fall.
Read My Lips: it’s time for women to stay on top of their heart health and get regular cholesterol screenings.
This guest blog by Laura Marrone and Pratik Shukla, MD, assistant professor of radiology at Rutgers New Jersey Medical School explores uterine fibroid embolization as a way to treat uterine fibroids.
Every July, individuals around the world raise awareness for uterine fibroids, which affect an estimated 26 million women of reproductive age in the United States. SWHR is dedicated to raising awareness about the effects of uterine fibroids on women’s livelihoods.
For Infertility Awareness Month, and in every month moving forward, SWHR is working to advance research, policy, and education on infertility and improve the lives of those affected.
To bring attention to Alzheimer's and Brain Awareness Month in June, SWHR released a statement of priority areas that could eliminate gaps in delays in Alzheimer’s disease diagnoses for women, among other things.
During the “Emerging Topics in Women’s Health: A Focus on Uterine Health” SWHR hosted a panel of women's health experts to discuss ways in which researchers, clinicians, and policy makers can collaborate to address disparities in uterine health.
SWHR presented on its women’s eye health disparities paper during a Biology of Sex Differences session at the OSSD 2023 Annual Meeting in Calgary, Alberta, Canada.